
aXichem Investor Relations Material
Latest events

Q1 2025
aXichem

Q1 2025
22 May, 2025

Q4 2024
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from aXichem
Access all reports
aXichem AB is a Swedish biotechnology company focused on developing natural analogue ingredients. Its flagship product, phenylcapsaicin, is a synthetic version of capsaicin used in various industries, including animal feed, dietary supplements, and marine applications. The company's solutions include aXivite, which is used in health supplements to support weight management and gut health, and aXiphen, a bio-repellent applied in agriculture, marine antifouling, and animal feed to promote health and prevent issues like salmonella in poultry. The company is headquartered in Malmö, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
AXIC
Country
🇸🇪 Sweden